Showing results (391-400 of 4,241) with videos related to
Sort By:
Pageof 425
Journal for Immunotherapy of Cancer|April 17, 2025
LILRB2 blockade facilitates macrophage repolarization and enhances T cell-mediated antitumor immunityDes C Jones, Lorraine Irving, Rebecca Dudley, et al.Journal for Immunotherapy of Cancer|April 18, 2025
Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2vHana Matuskova, Pavel Marasek, Vladyslav Mazhara, et al.Journal for Immunotherapy of Cancer|April 17, 2025
T-bet overexpression enhances CAR T cell effector functions and antigen sensitivityJennifer M Cimons, Kole R DeGolier, Samuel D Burciaga, et al.Journal for Immunotherapy of Cancer|May 24, 2025
Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: a randomized clinical trialWanpeng Li, Tian Wang, Haoyuan Xu, et al.Journal for Immunotherapy of Cancer|May 19, 2025
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trialJason J Luke, Katherine Bever, F Stephen Hodi, et al.Journal for Immunotherapy of Cancer|May 16, 2025
Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanomaRiyaben P Patel, Lydia Rui Jia Lim, Reem Saleh, et al.Journal for Immunotherapy of Cancer|May 13, 2025
Regional distribution of HLA frequencies in the USA: implications for TCR-based therapiesChristian Roy, Tomasz Sewastianik, Ileana Saenz, et al.Journal for Immunotherapy of Cancer|May 11, 2025
The cold immunological landscape of ATM-deficient cancersSonali Sinha, Victor Ng, Ardijana Novaj, et al.Journal for Immunotherapy of Cancer|May 11, 2025
Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancerYangyang Jia, Yanru Wang, Guanghao Zhao, et al.Journal for Immunotherapy of Cancer|May 11, 2025
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion proteinGiulia Rotta, Eleonora Prodi, Frauke Seehusen, et al.Pageof 425